The 20th Annual Oligonucleotide Therapeutics Society Meeting was a resounding success!
Join leading experts in the field at the OTS Annual Meeting which will feature the latest developments from the various oligonucleotide-based disciplines.
The Oligonucleotide Therapeutics Society (OTS) Annual Meeting is a forum for the realization of the Society's mission and goals, to foster academic and industry-based research for the development of oligonucleotide therapeutics. The meeting serves as a continuum for dialogue and discussion among industry, academia and health authorities to educate and share progress on the basic research and therapeutic development of oligonucleotides, including antisense, siRNA, immunostimulatory and aptamer applications, RNA/DNA editing and mRNA therapeutics as well as basic RNA research. Leaders in the field from across the globe alongside students (the Next Gen) will present in both general session and poster sessions.
The Annual Meeting is open to anyone interested or involved in oligonucleotide therapeutics. The OTS offers scholarships, awards and travel grants annually.
For details visit:
Registration and abstract submissions will open by early May and will be announced via email and social media.
